HRT Financial LP, recognized as a 10% owner of Shuttle Pharmaceuticals Holdings Inc., executed a strategic acquisition of the company's common equity on July 1, 2026. The firm purchased 3,959 shares at a unit price of $3.30, resulting in a total transaction value of $13,064. This acquisition immediately increased HRT Financial LP's direct holdings to 82,556 shares of Shuttle Pharmaceuticals Holdings Inc. common stock.
The insider transaction occurred against a backdrop of significant price depreciation for Shuttle Pharmaceuticals. The stock was trading at $3.59, a level hovering near its 52-week low of $2.90. Over the preceding year, the equity has declined by more than 91%. Recent market data indicates intensified selling pressure, with the stock experiencing a decline of approximately 10% over the last week. The regulatory filing for this transaction was submitted via Form 4 with the Securities and Exchange Commission, covering the period ending June 29, 2026. Adam Nunes signed the filing on July 2, 2026.
Concurrently, Shuttle Pharmaceuticals has finalized its merger with United Dogecoin Inc., rendering United Dogecoin a wholly owned subsidiary. As a component of this corporate restructuring, Shuttle Pharmaceuticals issued 8,000 shares of Series B-1 Convertible Preferred Stock to United Dogecoin equity holders. These preferred shares are convertible into approximately 32,264,000 shares of common stock, contingent upon receiving stockholder approval. Furthermore, United Dogecoin has announced the acquisition of ElphaPex DG1+ mining units and secured a mining facility with access to renewable energy. These mining units are projected to commence operations within approximately 60 days, with a focus on mining Dogecoin and Litecoin.
In a related corporate action, Shuttle Pharmaceuticals has approved a 10-for-1 reverse stock split of its common stock. This split is scheduled to become effective at 12:01 a.m. Eastern Time. Following the split, the stock will continue trading on the Nasdaq Capital Market under the existing symbol on a split-adjusted basis. Additionally, the company has confirmed a purchase order option for up to 3,000 ElphaPex Scrypt mining rigs, signaling an expansion of its mining capabilities. These developments underscore Shuttle Pharmaceuticals' strategic pivot toward the cryptocurrency mining sector through its subsidiary, United Dogecoin.